<DOC>
	<DOCNO>NCT02928263</DOCNO>
	<brief_summary>A retrospective study evaluate healthcare cost resource utilization patient metastatic renal cell carcinoma treat IV oral agent</brief_summary>
	<brief_title>Healthcare Cost Resource Utilization Related Metastatic Renal Cell Carcinoma Treatment With Intravenous Oral Agents</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Diagnosis metastatic renal cell carcinoma Prescription/administration one IV oral agent examine study Patients primary cancer diagnosis RCC diagnosis Patients pregnancy HIV/AIDS</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>